Literature DB >> 28939687

RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice.

Zidong Donna Fu1, Felcy P Selwyn1, Julia Yue Cui1, Curtis D Klaassen2.   

Abstract

Intestinal bacteria can affect xenobiotic metabolism through both direct bacterial enzyme-catalyzed modification of the xenobiotics and indirect alterations of the expression of host genes. To determine how intestinal bacteria affect the expression of host xenobiotic-processing genes (XPGs), the mRNA profiles of 303 XPGs were characterized by RNA sequencing in four intestinal sections and compared with that in the liver from adult male conventional (CV) and germ-free (GF) mice. Fifty-four XPGs were not expressed in the intestine of either CV or GF mice. The GF condition altered the expression of 116 XPGs in at least one intestinal section but had no effect on 133 XPGs. Many cytochrome P450 family members such as Cyp1a, Cyp2b10, Cyp2c, and most Cyp3a members, as well as carboxylesterase (Ces) 2a were expressed lower in the intestine of GF than CV mice. In contrast, GF mice had higher intestinal expression of some phase I oxidases (alcohol dehydrogenase 1, aldehyde dehydrogenase a1l1 and 4a1, as well as flavin monooxygenase 5) and phase II conjugation enzymes (UDP-glucuronosyltransferase 1a1, and sulfotransferase 1c2, 1d1, and 2b1). Several transporters in the intestine, such as bile acid transporters (apical sodium-dependent bile acid transporter, organic solute transporter α and β), peptide transporter 1, and multidrug and toxin extrusion protein 1, exhibited higher expression in GF mice. In conclusion, lack of intestinal bacteria alters the expression of a large number of XPGs in the host intestine, some of which are section specific. Cyp3a is downregulated in both the liver and intestine of GF mice, which probably contributes to altered xenobiotic metabolism.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28939687      PMCID: PMC5676297          DOI: 10.1124/dmd.117.077313

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  41 in total

1.  Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice.

Authors:  Julia Yue Cui; Helen J Renaud; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

Review 2.  Human gut microbiota plays a role in the metabolism of drugs.

Authors:  Lenka Jourova; Pavel Anzenbacher; Eva Anzenbacherova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2016-08-02       Impact factor: 1.245

3.  Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Iván L Csanaky; Youcai Zhang; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2015-07-21       Impact factor: 3.922

4.  Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression.

Authors:  Dylan P Hartley; Xudong Dai; Yudong D He; Edward J Carlini; Bonnie Wang; Su-Er W Huskey; Roger G Ulrich; Thomas H Rushmore; Raymond Evers; David C Evans
Journal:  Mol Pharmacol       Date:  2004-05       Impact factor: 4.436

5.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

Authors:  Sama I Sayin; Annika Wahlström; Jenny Felin; Sirkku Jäntti; Hanns-Ulrich Marschall; Krister Bamberg; Bo Angelin; Tuulia Hyötyläinen; Matej Orešič; Fredrik Bäckhed
Journal:  Cell Metab       Date:  2013-02-05       Impact factor: 27.287

6.  Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice.

Authors:  Takuya Kuno; Mio Hirayama-Kurogi; Shingo Ito; Sumio Ohtsuki
Journal:  Mol Pharm       Date:  2016-07-20       Impact factor: 4.939

7.  Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics.

Authors:  Felcy Pavithra Selwyn; Sunny Lihua Cheng; Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-11-19       Impact factor: 3.922

Review 8.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

Review 9.  The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs.

Authors:  Maja Stojančević; Gordana Bojić; Hani Al Salami; Momir Mikov
Journal:  Curr Issues Mol Biol       Date:  2013-09-04       Impact factor: 2.081

10.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

View more
  16 in total

1.  Gut Microbiota Modulates Interactions Between Polychlorinated Biphenyls and Bile Acid Homeostasis.

Authors:  Sunny Lihua Cheng; Xueshu Li; Hans-Joachim Lehmler; Brian Phillips; Danny Shen; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2018-12-01       Impact factor: 4.849

2.  Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI01.

Authors:  Jiafeng Xia; Shiman Jiang; Longxian Lv; Wenrui Wu; Qiangqiang Wang; Qiaomai Xu; Jianzhong Ye; Daiqiong Fang; Yating Li; Jingjing Wu; Xiaoyuan Bian; Liya Yang; Huiyong Jiang; Kaicen Wang; Ren Yan; Lanjuan Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-19       Impact factor: 4.813

Review 3.  The promise of the gut microbiome as part of individualized treatment strategies.

Authors:  Daniel A Schupack; Ruben A T Mars; Dayne H Voelker; Jithma P Abeykoon; Purna C Kashyap
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

Review 4.  Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

5.  Coordinate regulation of long non-coding RNAs and protein-coding genes in germ-free mice.

Authors:  Joseph Dempsey; Angela Zhang; Julia Yue Cui
Journal:  BMC Genomics       Date:  2018-11-21       Impact factor: 3.969

Review 6.  Interplay Between the Host, the Human Microbiome, and Drug Metabolism.

Authors:  Robert G Nichols; Jeffrey M Peters; Andrew D Patterson
Journal:  Hum Genomics       Date:  2019-06-11       Impact factor: 4.639

7.  Organ-level protein networks as a reference for the host effects of the microbiome.

Authors:  Robert H Mills; Jacob M Wozniak; Alison Vrbanac; Anaamika Campeau; Benoit Chassaing; Andrew Gewirtz; Rob Knight; David J Gonzalez
Journal:  Genome Res       Date:  2020-01-28       Impact factor: 9.043

Review 8.  The relationship between the gut microbiome and host gene expression: a review.

Authors:  Robert G Nichols; Emily R Davenport
Journal:  Hum Genet       Date:  2020-11-22       Impact factor: 4.132

9.  Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran.

Authors:  Robert G Nichols; Jingtao Zhang; Jingwei Cai; Iain A Murray; Imhoi Koo; Philip B Smith; Gary H Perdew; Andrew D Patterson
Journal:  Metabolites       Date:  2019-12-18

Review 10.  How the AHR Became Important in Intestinal Homeostasis-A Diurnal FICZ/AHR/CYP1A1 Feedback Controls Both Immunity and Immunopathology.

Authors:  Agneta Rannug
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.